Carregant...

Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells

<p>Abstract</p> <p>Background</p> <p>Chemoresistance is a serious problem in pancreatic cancer, but the mechanism of resistance and strategies against the resistance have not been elucidated. We examined the potential of the phosphatidylinositol 3-kinase (PI3K)/Akt inhi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Masaki Tsutomu, Kimura Shoji, Hossain Mohammad, Sano Takanori, Izuishi Kunihiko, Fujiwara Masao, Suzuki Yasuyuki
Format: Artigo
Idioma:Inglês
Publicat: BMC 2008-11-01
Col·lecció:Journal of Experimental & Clinical Cancer Research
Accés en línia:http://www.jeccr.com/content/27/1/76
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!